BRCA1 and BRCA2: different roles in a common pathway of genome protection

The proteins encoded by the two major breast cancer susceptibility genes, BRCA1 and BRCA2, work in a common pathway of genome protection. However, the two proteins work at different stages in the DNA damage response (DDR) and in DNA repair. BRCA1 is a pleiotropic DDR protein that functions in both checkpoint activation and DNA repair, whereas BRCA2 is a mediator of the core mechanism of homologous recombination. The links between the two proteins are not well understood, but they must exist to explain the marked similarity of human cancer susceptibility that arises with germline mutations in these genes. As discussed here, the proteins work in concert to protect the genome from double-strand DNA damage during DNA replication.

[1]  C. C. Twort,et al.  THE ETIOLOGY OF BREAST CANCER , 1932 .

[2]  Phang-lang Chen,et al.  Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. , 2002, Cancer research.

[3]  Suhwan Chang,et al.  Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations. , 2009, The Journal of clinical investigation.

[4]  Feng Zhang,et al.  PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response , 2009, Current Biology.

[5]  Junjie Chen,et al.  PALB2 is an integral component of the BRCA complex required for homologous recombination repair , 2009, Proceedings of the National Academy of Sciences.

[6]  Maximina H. Yun,et al.  CtIP-BRCA1 modulates the choice of DNA double-strand break repair pathway throughout the cell cycle , 2009, Nature.

[7]  L. Chodosh,et al.  Uterus Hyperplasia and Increased Carcinogen-Induced Tumorigenesis in Mice Carrying a Targeted Mutation of the Chk2 Phosphorylation Site in Brca1 , 2004, Molecular and Cellular Biology.

[8]  D. Meek.  Tumour suppression by p53: a role for the DNA damage response? , 2009, Nature Reviews Cancer.

[9]  D. Wigley,et al.  CeBRC-2 stimulates D-loop formation by RAD-51 and promotes DNA single-strand annealing. , 2006, Journal of molecular biology.

[10]  W. Foulkes,et al.  Inherited susceptibility to common cancers. , 2008, The New England journal of medicine.

[11]  Wolf-Dietrich Heyer,et al.  Human BRCA2 protein promotes RAD51 filament formation on RPA-covered ssDNA , 2010, Nature Structural &Molecular Biology.

[12]  J. Peto,et al.  p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours , 1998, Oncogene.

[13]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Peterse,et al.  Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer , 2007, Proceedings of the National Academy of Sciences.

[15]  M. Yaffe,et al.  14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response. , 2009, DNA repair.

[16]  Junjie Chen,et al.  CCDC98 is a BRCA1-BRCT domain–binding protein involved in the DNA damage response , 2007, Nature Structural &Molecular Biology.

[17]  Zhihui Feng,et al.  Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair , 2004, Molecular and Cellular Biology.

[18]  A. Berns,et al.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.

[19]  H. Nevanlinna,et al.  The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer , 2008, Oncogene.

[20]  L. Norton,et al.  Heterogenic Loss of the Wild-Type BRCA Allele in Human Breast Tumorigenesis , 2007, Annals of Surgical Oncology.

[21]  V. Godfrey,et al.  Mammary tumor formation in p53- and BRCA1-deficient mice. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[22]  Jeremy M. Stark,et al.  53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks , 2010, Cell.

[23]  E. Berns,et al.  Is TP53 dysfunction required for BRCA1-associated carcinogenesis? , 1999, Molecular and Cellular Endocrinology.

[24]  Y Taya,et al.  DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.

[25]  F. Couch,et al.  Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. , 2006, Molecular cell.

[26]  Kum Kum Khanna,et al.  BRCA1-BARD1 Complexes Are Required for p53Ser-15 Phosphorylation and a G1/S Arrest following Ionizing Radiation-induced DNA Damage* , 2004, Journal of Biological Chemistry.

[27]  Steven P Gygi,et al.  Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response , 2007, Science.

[28]  W. Foulkes.  Molecular Origins of Cancer Inherited Susceptibility to Common Cancers , 2008 .

[29]  Anne M. Bowcock,et al.  Identification of a RING protein that can interact in vivo with the BRCA1 gene product , 1996, Nature Genetics.

[30]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. , 2003, Cancer research.

[31]  Ashok R. Venkitaraman,et al.  The BRC Repeats of BRCA2 Modulate the DNA-Binding Selectivity of RAD51 , 2009, Cell.

[32]  Bo Xu,et al.  Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. , 2002, Cancer research.

[33]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[34]  S. Elledge,et al.  ATM–Chk2–p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency , 2006, The EMBO journal.

[35]  M. Hande,et al.  Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis. , 2002, Cancer research.

[36]  Aedín C Culhane,et al.  RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites , 2007, Science.

[37]  G E Tomlinson,et al.  BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. , 1999, Cancer research.

[38]  A. Whittemore,et al.  BRCA2 Mutation-associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles From Tissue Microarrays , 2007, The American journal of surgical pathology.

[39]  B. Koller,et al.  BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgene , 1999, Oncogene.

[40]  A. Yasui,et al.  Rapid Recruitment of BRCA1 to DNA Double-Strand Breaks Is Dependent on Its Association with Ku80 , 2008, Molecular and Cellular Biology.

[41]  S. Kowalczykowski,et al.  Purified human BRCA2 stimulates RAD51-mediated recombination , 2010, Nature.

[42]  Edward H Egelman,et al.  Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2 , 2007, Nature Structural &Molecular Biology.

[43]  B. Gusterson,et al.  Concomitant inactivation of p53 and Chk2 in breast cancer , 2002, Oncogene.

[44]  C. Deng,et al.  Roles of BRCA1 and its interacting proteins , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[45]  Alan Ashworth,et al.  Structural basis for recruitment of BRCA2 by PALB2 , 2009, EMBO reports.

[46]  M. Brenneman,et al.  Depletion of DSS1 protein disables homologous recombinational repair in human cells. , 2010, Mutation research.

[47]  A. Jeyasekharan,et al.  The Carboxyl Terminus of Brca2 Links the Disassembly of Rad51 Complexes to Mitotic Entry , 2009, Current Biology.

[48]  Link,et al.  Mouse models of BRCA 1 and BRCA 2 deficiency : past lessons , current understanding and future prospects , 2022 .

[49]  J. Jonkers,et al.  Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects , 2006, Oncogene.

[50]  S. Elledge,et al.  Direct DNA binding by Brca1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  B. Gusterson,et al.  Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions , 1999, Oncogene.

[52]  Junjie Chen,et al.  Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response , 2007, Science.

[53]  T. Pandita,et al.  Rad52 inactivation is synthetically lethal with BRCA2 deficiency , 2010, Proceedings of the National Academy of Sciences.

[54]  Fan Zhang,et al.  PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2 , 2009, Molecular Cancer Research.

[55]  M. Skolnick,et al.  A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. , 1995, JAMA.

[56]  D. Wazer,et al.  DSS1 is required for the stability of BRCA2 , 2006, Oncogene.

[57]  Xiaochun Yu,et al.  CCDC98 targets BRCA1 to DNA damage sites , 2007, Nature Structural &Molecular Biology.

[58]  G. Giles,et al.  Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. , 1999, Cancer research.

[59]  J. Hamada,et al.  Increased oxidative DNA damage in mammary tumor cells by continuous epidermal growth factor stimulation. , 2001, Journal of the National Cancer Institute.

[60]  J. Jonkers,et al.  Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression , 2011, The Journal of pathology.

[61]  S. West,et al.  CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair , 2005, Nature.

[62]  S. Powell,et al.  BRCA2 keeps Rad51 in line. High-fidelity homologous recombination prevents breast and ovarian cancer? , 2002, Molecular cell.

[63]  Bo Xu,et al.  Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation , 2001, Molecular and Cellular Biology.

[64]  Jeremy M. Stark,et al.  Suppression of the DNA repair defects of BRCA2-deficient cells with heterologous protein fusions. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[65]  A. Meindl,et al.  Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer , 2011, Human mutation.

[66]  B. Koller,et al.  Brca1 controls homology-directed DNA repair. , 1999, Molecular cell.

[67]  R. Mason,et al.  The metabolism of 17 beta-estradiol by lactoperoxidase: a possible source of oxidative stress in breast cancer. , 1994, Carcinogenesis.

[68]  T. Mak,et al.  Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutation , 1997, Nature Genetics.

[69]  T. Ohta,et al.  Mass Spectrometric and Mutational Analyses Reveal Lys-6-linked Polyubiquitin Chains Catalyzed by BRCA1-BARD1 Ubiquitin Ligase* , 2004, Journal of Biological Chemistry.

[70]  M. Jasin,et al.  BRCA2 is required for homology-directed repair of chromosomal breaks. , 2001, Molecular cell.

[71]  C. Deng,et al.  Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation , 2000, Oncogene.

[72]  Phang-lang Chen,et al.  BRCA1 Facilitates Microhomology-mediated End Joining of DNA Double Strand Breaks* , 2002, The Journal of Biological Chemistry.

[73]  O. Johannsson,et al.  Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes , 2009, Breast Cancer Research.

[74]  Junjie Chen,et al.  BRCA1 and its toolbox for the maintenance of genome integrity , 2010, Nature Reviews Molecular Cell Biology.

[75]  Xiaohua Wu,et al.  Cell Cycle-dependent Complex Formation of BRCA1·CtIP·MRN Is Important for DNA Double-strand Break Repair* , 2008, Journal of Biological Chemistry.

[76]  C. Hudis,et al.  Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women , 2011, Breast Cancer Research and Treatment.

[77]  M. Erdos,et al.  BRCA1 inhibition of estrogen receptor signaling in transfected cells. , 1999, Science.

[78]  Ashok R Venkitaraman,et al.  Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. , 2009, Annual review of pathology.

[79]  R. Scully,et al.  Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks. , 2007, DNA repair.

[80]  P. Pharoah,et al.  Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours , 1999, Genes, chromosomes & cancer.

[81]  Fergus J Couch,et al.  Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice. , 2011, Gastroenterology.

[82]  B. Koller,et al.  Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities , 1996, Nature Genetics.

[83]  K. Nakao,et al.  Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[84]  C. Deng,et al.  Knockout mouse models and mammary tumorigenesis. , 2001, Seminars in cancer biology.

[85]  L. Bennett,et al.  Spontaneous and Irradiation-Induced Tumor Susceptibility in Brca2 Germline Mutant Mice and Cooperative Effects with a p53 Germline Mutation , 2006, Toxicologic pathology.

[86]  F. Couch,et al.  Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene , 1996, Human mutation.

[87]  Fred H. Gage,et al.  BRCA1 tumor suppression occurs via heterochromatin mediated silencing , 2011, Nature.

[88]  S. Elledge,et al.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. , 1999, Science.

[89]  N. Pavletich,et al.  The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA–ssDNA junction , 2005, Nature.

[90]  Jeremy M. Stark,et al.  Genetic Steps of Mammalian Homologous Repair with Distinct Mutagenic Consequences , 2004, Molecular and Cellular Biology.

[91]  A. Venkitaraman,et al.  Abnormal Cytokinesis in Cells Deficient in the Breast Cancer Susceptibility Protein BRCA2 , 2004, Science.

[92]  M. Hande,et al.  A role for Brca1 in chromosome end maintenance. , 2006, Human molecular genetics.

[93]  A. Bowcock,et al.  The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression* , 1998, The Journal of Biological Chemistry.

[94]  Junjie Chen,et al.  BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP. , 2006, Genes & development.

[95]  S. Powell,et al.  Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. , 2001, Cancer research.

[96]  D. Sgroi,et al.  Utility of DNA Repair Protein Foci for the Detection of Putative BRCA1 Pathway Defects in Breast Cancer Biopsies , 2009, Molecular Cancer Research.

[97]  A. Børresen-Dale,et al.  BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations , 2010, BMC Cancer.

[98]  R. Greenberg,et al.  Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. , 2006, Genes & development.

[99]  N. Polissar,et al.  The etiology of breast cancer characteristic alterations in hydroxyl radical‐induced dna base lesions during oncogenesis with potential for evaluating incidence risk , 1993, Cancer.

[100]  M. Stratton,et al.  The genetics of breast cancer susceptibility. , 1998, Annual review of genetics.

[101]  A. Bowcock,et al.  Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. , 1997, The New England journal of medicine.

[102]  Y. Houvras,et al.  Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl , 1997, Nature.

[103]  B. Ponder,et al.  Involvement of Brca2 in DNA repair. , 1998, Molecular cell.

[104]  S. West,et al.  The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA , 2010, Nature Structural &Molecular Biology.

[105]  Tom L. Blundell,et al.  Insights into DNA recombination from the structure of a RAD51–BRCA2 complex , 2002, Nature.

[106]  Wen-Hwa Lee,et al.  BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. , 2002, Science.

[107]  鮫島 浩,et al.  Population-based study からみた神経予後不良因子の検討 , 2009 .

[108]  D. Sgroi,et al.  BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function , 2001, Cell.

[109]  Patrick Dowd,et al.  Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.

[110]  J. Yager,et al.  The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. , 2001, Cancer research.

[111]  J. Eyfjörd,et al.  A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.

[112]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[113]  Alan D. D'Andrea.  Fanconi anemia , 2003, Current Biology.

[114]  Ashok R Venkitaraman,et al.  Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer. , 2010, Cancer cell.

[115]  N. Pavletich,et al.  The BRCA2-interacting protein DSS1 is vital for DNA repair, recombination, and genome stability in Ustilago maydis. , 2003, Molecular cell.